González, L.M.; Robles, N.R.; Mota-Zamorano, S.; Valdivielso, J.M.; López-Gómez, J.; Gervasini, G.
Genetic Variants in PGE2 Receptors Modulate the Risk of Nephrosclerosis and Clinical Outcomes in These Patients. J. Pers. Med. 2021, 11, 772.
https://doi.org/10.3390/jpm11080772
AMA Style
González LM, Robles NR, Mota-Zamorano S, Valdivielso JM, López-Gómez J, Gervasini G.
Genetic Variants in PGE2 Receptors Modulate the Risk of Nephrosclerosis and Clinical Outcomes in These Patients. Journal of Personalized Medicine. 2021; 11(8):772.
https://doi.org/10.3390/jpm11080772
Chicago/Turabian Style
González, Luz MarĂa, Nicolás Roberto Robles, Sonia Mota-Zamorano, JosĂ© Manuel Valdivielso, Juan LĂłpez-GĂłmez, and Guillermo Gervasini.
2021. "Genetic Variants in PGE2 Receptors Modulate the Risk of Nephrosclerosis and Clinical Outcomes in These Patients" Journal of Personalized Medicine 11, no. 8: 772.
https://doi.org/10.3390/jpm11080772
APA Style
González, L. M., Robles, N. R., Mota-Zamorano, S., Valdivielso, J. M., López-Gómez, J., & Gervasini, G.
(2021). Genetic Variants in PGE2 Receptors Modulate the Risk of Nephrosclerosis and Clinical Outcomes in These Patients. Journal of Personalized Medicine, 11(8), 772.
https://doi.org/10.3390/jpm11080772